TLRY's 94.5% surge, record fiscal Q1 revenues, and expanding medical cannabis footprint fuel optimism amid global challenges.
C annabis investors recently saw a jolt of optimism after President Donald Trump signaled support for covering CBD oil under ...
Aurora Cannabis reports Q2-2026 revenue growth with stronger international sales but posts net loss and negative free cash flow. Learn why ACB stock is a hold.
Village Farms' surge reflects its pivot to a pure-play cannabis model, record profitability and a confident $10M share ...
Explore Curaleaf Holdings, Inc.'s earnings, market outlook, and upside tied to U.S. cannabis legalization. Click to see if ...
The AdvisorShares Pure U.S. Cannabis ETF was up by 1.2% and the Amplify Alternative Harvest ETF gained 1.5%, the day after a positive election result for adult-use cannabis in Virginia. Among ...
Looking ahead, Aurora expects its third-quarter 2026 consolidated revenue to increase year over year, led by 8% to 12% growth in global medical cannabis sales. Management also projects continued ...
Shares of Canadian cannabis producers fell in the premarket on Tuesday after their Alberta-based peer SNDL (SNDL) reported ...
A new push to limit certain cannabis products by top American legal officials dampened the buzz of some marijuana companies ...
Cannabis stocks once soared to billion-dollar valuations, but now trade at penny stock levels after the hype faded. 40 U.S. states allow medical marijuana, 24 permit recreational use, yet federal ...
The video comes just a few weeks after Trump said he was considering reclassifying marijuana on the federal level as a less dangerous drug. Several states already allow marijuana for recreational ...
A decade from now, investors may very well look back and proclaim the cannabis industry to be the greatest growth opportunity of our generation. We know the demand is there given the tens of billions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results